512 related articles for article (PubMed ID: 18025305)
21. BH3 domains other than Bim and Bid can directly activate Bax/Bak.
Du H; Wolf J; Schafer B; Moldoveanu T; Chipuk JE; Kuwana T
J Biol Chem; 2011 Jan; 286(1):491-501. PubMed ID: 21041309
[TBL] [Abstract][Full Text] [Related]
22. Bid chimeras indicate that most BH3-only proteins can directly activate Bak and Bax, and show no preference for Bak versus Bax.
Hockings C; Anwari K; Ninnis RL; Brouwer J; O'Hely M; Evangelista M; Hinds MG; Czabotar PE; Lee EF; Fairlie WD; Dewson G; Kluck RM
Cell Death Dis; 2015 Apr; 6(4):e1735. PubMed ID: 25906158
[TBL] [Abstract][Full Text] [Related]
23. Predominant requirement of Bax for apoptosis in HCT116 cells is determined by Mcl-1's inhibitory effect on Bak.
Wang C; Youle RJ
Oncogene; 2012 Jun; 31(26):3177-89. PubMed ID: 22056880
[TBL] [Abstract][Full Text] [Related]
24. Caspase-independent induction of apoptosis in human melanoma cells by the proapoptotic Bcl-2-related protein Nbk / Bik.
Oppermann M; Geilen CC; Fecker LF; Gillissen B; Daniel PT; Eberle J
Oncogene; 2005 Nov; 24(49):7369-80. PubMed ID: 16007125
[TBL] [Abstract][Full Text] [Related]
25. Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma.
Gillissen B; Wendt J; Richter A; Richter A; Müer A; Overkamp T; Gebhardt N; Preissner R; Belka C; Dörken B; Daniel PT
J Cell Biol; 2010 Mar; 188(6):851-62. PubMed ID: 20308427
[TBL] [Abstract][Full Text] [Related]
26. Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation.
Chen S; Dai Y; Harada H; Dent P; Grant S
Cancer Res; 2007 Jan; 67(2):782-91. PubMed ID: 17234790
[TBL] [Abstract][Full Text] [Related]
27. Contribution of BH3-domain and Transmembrane-domain to the Activity and Interaction of the Pore-forming Bcl-2 Proteins Bok, Bak, and Bax.
Stehle D; Grimm M; Einsele-Scholz S; Ladwig F; Johänning J; Fischer G; Gillissen B; Schulze-Osthoff K; Essmann F
Sci Rep; 2018 Aug; 8(1):12434. PubMed ID: 30127460
[TBL] [Abstract][Full Text] [Related]
28. MCL-1ES induces MCL-1L-dependent BAX- and BAK-independent mitochondrial apoptosis.
Kim JH; Bae J
PLoS One; 2013; 8(11):e79626. PubMed ID: 24260268
[TBL] [Abstract][Full Text] [Related]
29. Translocation of a Bak C-terminus mutant from cytosol to mitochondria to mediate cytochrome C release: implications for Bak and Bax apoptotic function.
Ferrer PE; Frederick P; Gulbis JM; Dewson G; Kluck RM
PLoS One; 2012; 7(3):e31510. PubMed ID: 22442658
[TBL] [Abstract][Full Text] [Related]
30. The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines.
Radetzki S; Köhne CH; von Haefen C; Gillissen B; Sturm I; Dörken B; Daniel PT
Oncogene; 2002 Jan; 21(2):227-38. PubMed ID: 11803466
[TBL] [Abstract][Full Text] [Related]
31. Myeloid cell leukemia-1 is an important apoptotic survival factor in triple-negative breast cancer.
Goodwin CM; Rossanese OW; Olejniczak ET; Fesik SW
Cell Death Differ; 2015 Dec; 22(12):2098-106. PubMed ID: 26045046
[TBL] [Abstract][Full Text] [Related]
32. Crosstalk among Bcl-2 family members in B-CLL: seliciclib acts via the Mcl-1/Noxa axis and gradual exhaustion of Bcl-2 protection.
Hallaert DY; Spijker R; Jak M; Derks IA; Alves NL; Wensveen FM; de Boer JP; de Jong D; Green SR; van Oers MH; Eldering E
Cell Death Differ; 2007 Nov; 14(11):1958-67. PubMed ID: 17703234
[TBL] [Abstract][Full Text] [Related]
33. In non-transformed cells Bak activates upon loss of anti-apoptotic Bcl-XL and Mcl-1 but in the absence of active BH3-only proteins.
Senft D; Weber A; Saathoff F; Berking C; Heppt MV; Kammerbauer C; Rothenfusser S; Kellner S; Kurgyis Z; Besch R; Häcker G
Cell Death Dis; 2015 Nov; 6(11):e1996. PubMed ID: 26610208
[TBL] [Abstract][Full Text] [Related]
34. MOMP in the absence of BH3-only proteins.
García Sáez AJ; Villunger A
Genes Dev; 2016 Apr; 30(8):878-80. PubMed ID: 27083995
[TBL] [Abstract][Full Text] [Related]
35. Synergistic induction of apoptosis by p53-inducible Bcl-2 family proteins Noxa and Puma.
Nakajima W; Tanaka N
J Nippon Med Sch; 2007 Apr; 74(2):148-57. PubMed ID: 17507791
[TBL] [Abstract][Full Text] [Related]
36. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells.
Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS
Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214
[TBL] [Abstract][Full Text] [Related]
37. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins.
Willis SN; Chen L; Dewson G; Wei A; Naik E; Fletcher JI; Adams JM; Huang DC
Genes Dev; 2005 Jun; 19(11):1294-305. PubMed ID: 15901672
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial permeabilization relies on BH3 ligands engaging multiple prosurvival Bcl-2 relatives, not Bak.
Uren RT; Dewson G; Chen L; Coyne SC; Huang DC; Adams JM; Kluck RM
J Cell Biol; 2007 Apr; 177(2):277-87. PubMed ID: 17452531
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor-related apoptosis-inducing ligand activates a lysosomal pathway of apoptosis that is regulated by Bcl-2 proteins.
Werneburg NW; Guicciardi ME; Bronk SF; Kaufmann SH; Gores GJ
J Biol Chem; 2007 Sep; 282(39):28960-28970. PubMed ID: 17686764
[TBL] [Abstract][Full Text] [Related]
40. Pseudomonas exotoxin A-mediated apoptosis is Bak dependent and preceded by the degradation of Mcl-1.
Du X; Youle RJ; FitzGerald DJ; Pastan I
Mol Cell Biol; 2010 Jul; 30(14):3444-52. PubMed ID: 20457813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
